-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
1/52
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
2/52
Dmitri Popov, PhD, Advanced MedicalTechnology and Systems Inc. , Canada.
Maliev Slava, Professor, VladicaucasianResearch Center of Russian Academy ofScience.
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
3/52
Key Words:
ROS Reactive Oxygen Species.
Neutrophils.
Macrophages.
Innate Immunity.
Adaptive Iimmunity.
Na Cl O Sodium Hypochlorite.
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
4/52
ROS Reactive Oxygen Species.
Reactive oxygen species(ROS) are chemically
reactive molecules containing oxygen.Examples include oxygenionsand peroxides.ROS are formed as a natural byproduct of thenormal metabolism of oxygenand haveimportant roles in cellsignalingand homeostasis.
http://en.wikipedia.org/wiki/Oxygenhttp://en.wikipedia.org/wiki/Ionhttp://en.wikipedia.org/wiki/Peroxidehttp://en.wikipedia.org/wiki/Oxygenhttp://en.wikipedia.org/wiki/Cell_signalinghttp://en.wikipedia.org/wiki/Cell_signalinghttp://en.wikipedia.org/wiki/Homeostasishttp://en.wikipedia.org/wiki/Homeostasishttp://en.wikipedia.org/wiki/Cell_signalinghttp://en.wikipedia.org/wiki/Cell_signalinghttp://en.wikipedia.org/wiki/Oxygenhttp://en.wikipedia.org/wiki/Peroxidehttp://en.wikipedia.org/wiki/Ionhttp://en.wikipedia.org/wiki/Oxygen -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
5/52
Treatment of acute severe deadly infectionsdiseases (Plague, Ebola, SARS Severe AcuteRespiratory Syndrome , MERS Middle East
Respiratory Syndrome) with I/V solutionswith Reactive Oxygen Species ( SodiumHypochlorite).
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
6/52
Plague is primarily a disease of rodents andtheir fleas, which can infect humans. It istransmitted between rodents by rodent fleas,
and can be transmitted to people when infectedrodent fleas bite them.
As with many primarily zoo-notic diseases,plague is a very severe disease in people, with
case fatality rates of 50-60% if left untreated.[WHO ]
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
7/52
Objective: Biological Weapon remain most dangerous threat in
the world. Bioterrorismis terrorisminvolving the intentional
release or dissemination ofbiological agents. Theseagents are bacteria,viruses, or toxins, and may be in anaturally occurring ora human-modified form. For theuse of this method in warfare, seebiological warfare.
The Working Group on Civilian Biodefense hasdeveloped consensus based
recommendations for measures to be taken by medicaland public health professionals following the use ofplague as a biological weapon against a civilianpopulation.
http://en.wikipedia.org/wiki/Terrorismhttp://en.wikipedia.org/wiki/Biological_agenthttp://en.wikipedia.org/wiki/Bacteriahttp://en.wikipedia.org/wiki/Virushttp://en.wikipedia.org/wiki/Biological_agenthttp://en.wikipedia.org/wiki/Toxinhttp://en.wikipedia.org/wiki/Biological_agenthttp://en.wikipedia.org/wiki/Bacteriahttp://en.wikipedia.org/wiki/Virushttp://en.wikipedia.org/wiki/Toxinhttp://en.wikipedia.org/wiki/Warhttp://en.wikipedia.org/wiki/Biological_warfarehttp://en.wikipedia.org/wiki/Warhttp://en.wikipedia.org/wiki/Biological_warfarehttp://en.wikipedia.org/wiki/Biological_warfarehttp://en.wikipedia.org/wiki/Biological_warfarehttp://en.wikipedia.org/wiki/Biological_warfarehttp://en.wikipedia.org/wiki/Warhttp://en.wikipedia.org/wiki/Toxinhttp://en.wikipedia.org/wiki/Virushttp://en.wikipedia.org/wiki/Bacteriahttp://en.wikipedia.org/wiki/Biological_agenthttp://en.wikipedia.org/wiki/Terrorism -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
8/52
A biological weapon is usefulto terroristsmainly as a method of creatingmass panic and disruption to a state or a
country.http://en.wikipedia.org/wiki/Bioterrorism
http://en.wikipedia.org/wiki/Terroristshttp://en.wikipedia.org/wiki/Bioterrorismhttp://en.wikipedia.org/wiki/Bioterrorismhttp://en.wikipedia.org/wiki/Terrorists -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
9/52
Under current United States law, bio-agentswhichhave been declared by the U.S. Department of Healthand HumanServicesor the U.S. Department ofAgricultureto have the "potential to pose a severethreat to public health and safety" are officially defined
as "select agents". The CDC categorizes these agents (A,B or C) and administers the Select Agent Program,which regulates the laboratories which may possess,use, or transfer select agents within the United States.As with US attempts to categorize harmful recreational
drugs, designer viruses are not yet categorized andavian H5N1 has been shown to achieve high mortalityand human-communication in a laboratory setting.
http://en.wikipedia.org/wiki/Bioterrorism#Category_A
http://en.wikipedia.org/wiki/United_States_lawhttp://en.wikipedia.org/wiki/U.S._Department_of_Health_and_Human_Serviceshttp://en.wikipedia.org/wiki/U.S._Department_of_Health_and_Human_Serviceshttp://en.wikipedia.org/wiki/U.S._Department_of_Health_and_Human_Serviceshttp://en.wikipedia.org/wiki/U.S._Department_of_Health_and_Human_Serviceshttp://en.wikipedia.org/wiki/U.S._Department_of_Health_and_Human_Serviceshttp://en.wikipedia.org/wiki/U.S._Department_of_Health_and_Human_Serviceshttp://en.wikipedia.org/wiki/U.S._Department_of_Agriculturehttp://en.wikipedia.org/wiki/U.S._Department_of_Health_and_Human_Serviceshttp://en.wikipedia.org/wiki/U.S._Department_of_Agriculturehttp://en.wikipedia.org/wiki/U.S._Department_of_Health_and_Human_Serviceshttp://en.wikipedia.org/wiki/U.S._Department_of_Agriculturehttp://en.wikipedia.org/wiki/U.S._Department_of_Agriculturehttp://en.wikipedia.org/wiki/Select_agentshttp://en.wikipedia.org/wiki/Select_agentshttp://en.wikipedia.org/wiki/Select_Agent_Programhttp://en.wikipedia.org/wiki/Select_Agent_Programhttp://en.wikipedia.org/wiki/Select_Agent_Programhttp://en.wikipedia.org/wiki/Select_agentshttp://en.wikipedia.org/wiki/U.S._Department_of_Agriculturehttp://en.wikipedia.org/wiki/U.S._Department_of_Agriculturehttp://en.wikipedia.org/wiki/U.S._Department_of_Health_and_Human_Serviceshttp://en.wikipedia.org/wiki/U.S._Department_of_Health_and_Human_Serviceshttp://en.wikipedia.org/wiki/Bio-agentshttp://en.wikipedia.org/wiki/Bio-agentshttp://en.wikipedia.org/wiki/Bio-agentshttp://en.wikipedia.org/wiki/United_States_law -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
10/52
Bubonic plague.Plague is a disease caused bythe Yersinia pestisbacterium. Rodents are the normalhost of plague, and the disease is transmitted tohumansby fleabites and occasionally by aerosolin theform of pneumonic plague. The disease has a history of
use in biological warfare dating back many centuries,and is considered a threat due to its ease of culture andability to remain in circulation among local rodents fora long period of time. The weaponized threat comesmainly in the form of pneumonic plague (infection by
inhalation).
It was the disease that caused the BlackDeathin Medieval Europe. http://en.wikipedia.org/wiki/Bioterrorism#Category
_A
http://en.wikipedia.org/wiki/Bubonic_plaguehttp://en.wikipedia.org/wiki/Yersinia_pestishttp://en.wikipedia.org/wiki/Fleahttp://en.wikipedia.org/wiki/Aerosolhttp://en.wikipedia.org/wiki/Pneumonic_plaguehttp://en.wikipedia.org/wiki/Pneumonic_plaguehttp://en.wikipedia.org/wiki/Pneumonic_plaguehttp://en.wikipedia.org/wiki/Aerosolhttp://en.wikipedia.org/wiki/Pneumonic_plaguehttp://en.wikipedia.org/wiki/Black_Deathhttp://en.wikipedia.org/wiki/Black_Deathhttp://en.wikipedia.org/wiki/Black_Deathhttp://en.wikipedia.org/wiki/Black_Deathhttp://en.wikipedia.org/wiki/Black_Deathhttp://en.wikipedia.org/wiki/Black_Deathhttp://en.wikipedia.org/wiki/Pneumonic_plaguehttp://en.wikipedia.org/wiki/Aerosolhttp://en.wikipedia.org/wiki/Fleahttp://en.wikipedia.org/wiki/Yersinia_pestishttp://en.wikipedia.org/wiki/Yersinia_pestishttp://en.wikipedia.org/wiki/Yersinia_pestishttp://en.wikipedia.org/wiki/Bubonic_plague -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
11/52
Category A
These high-priority agents pose a risk tonational security, can be easily transmitted and
disseminated, result in high mortality, havepotential major public health impact, maycause public panic, or require special action forpublic health preparedness.
http://en.wikipedia.org/wiki/Bioterrorism#Category_A
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
12/52
An aerosolized plague weapon could cause fever,cough, chest pain,
and hemoptysis with signs consistent with severepneumonia 1 to 6 days after exposure.
Rapid evolution of disease would occur in the 2 to 4days after symptom onset and would lead to septic shock with high mortality
without early treatment. Early treatment and prophylaxis with streptomycin or gentamicin or
the tetracycline or fluoroquinolone classes of antimicrobials would be advised. JAMA. 2000;283:2281-2290 www.jama.com http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
13/52
Plague Following Use of a Biological Weapon The epidemiology of plague following its use as a biological
weapon would differ substantially from that of naturallyoccurring infection.
Intentional dissemination of plague would most probably occur
via an aerosol of Y pestis, a mechanism that has been shown toproduce disease in nonhuman primates. A pneumonic plague outbreak would result with symptoms
initially resembling those of other severe respiratory illnesses. The size of the outbreak would depend on factors including the
quantity of biological agent used, characteristics of the strain,environmental conditions, and methods of aerosolization.
Symptoms would begin to occur 1 to 6 days following exposure,and people would die quickly following onset of symptoms.
http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
14/52
The bacteria migrate through cutaneo-lymphatics toregional lymph nodes where they are phagocytosedbut resist destruction.
They rapidly multiply causing destruction and
necrosis of lymph node architecture with subsequentbacteremia, septicemia, and endotoxemia can leadquickly to shock, disseminated intravascularcoagulation, and coma.
Mandell GL, Bennett JE, Dolin R, eds.
Principles and Practice of Infectious Diseases.NewYork, NY: Churchill
Livingstone; 1995:2070-2078http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
15/52
Patients typically develop symptoms of bubonic plague 2 to 8 days after being bitten by an infected flea. There is sudden onset of fever, chills, and weakness
and the development of an acutely swollen tender lymph node, or bubo, up to 1 day later.
Campbell GL, Dennis DT. Plague and other Yersinia infections. In: Fauci AS, Braunwald E, Isselbacher
KJ, et al, eds. Harrisons Principles of Internal Medicine. New York, NY: McGraw-Hill; 1998: 975-
983http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
16/52
The bubo most typically
develops in the groin, axilla, or cervical
Region and is often so painful
that it prevents patients from moving the affected area of the body. Buboes
are 1 to 10 cm in diameter, and the overlying
skin is erythematous.
Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases.NewYork, NY: Churchill
Livingstone; 1995:2070-2078
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
17/52
Septicemic plague may lead to disseminated
intravascular coagulation, necrosis of
small vessels, and purpuric skin lesions.
Gangrene of regions such as the digits andnose may also occur
in advanced disease, a process believed
responsible for the name black death in thesecond plague pandemic.
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
18/52
Secondary pneumonic plague develops
in a minority of patients with bubonic or primarysepticemic plague. This process, termed secondarypneumonic plague, develops via hematogenous
spread of plague bacilli to the lungs. Patients
commonly have symptoms of severebronchopneumonia, chest pain, dyspnea, cough,and hemoptysis.
Mandell GL, Bennett JE, Dolin R, eds. Principles andPractice of Infectious Diseases.NewYork, NY: Churchill
Livingstone; 1995:2070-2078
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
19/52
Plague Following Use of a Biological Weapon The pathogenesis and clinical manifestations of plague
following a biological attack would be notably different thannaturally occurring plague. Inhaled aerosolized Y pestisbacilli would cause primary pneumonic plague. The time
from exposure to aerosolized plague bacilli untildevelopment of first symptoms in humans and nonhumanprimates has been found to be 1 to 6 days and most often, 2
to 4 days. The first sign of illness would be expected to be fever with
cough and dyspnea, sometimes with the productionof bloody, watery, or less commonly, purulent sputum.http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
20/52
Prominent gastrointestinal symptoms, includingnausea, vomiting, abdominal pain, and diarrhea,might be present. The ensuing clinical findings ofprimary pneumonic plague are similar to those ofany severe rapidly progressive pneumonia and arequite similar to those of secondary pneumonic
plague. Clinical-pathological features may help
distinguish primary from secondary pneumonicplague.http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
21/52
In contrast to secondary pneumonic plague,
features of primary pneumonic plague
would include absence of buboes (except,
rarely, cervical buboes) and, on
pathologic examination, pulmonary disease
with areas of profound lobular exudation
and bacillary aggregation.http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
22/52
Laboratory studies may reveal leukocytosis
with toxic granulations, coagulationabnormalities, aminotransferase elevations,azotemia, and other evidence of multiorgan
failure. All are nonspecific findings associated withsepsis and systemic inflammatory responsesyndrome. The time from respiratory exposure todeath in humans is reported to have been between
2 to 6 days in epidemics during the pre-antibioticera, with a mean of 2 to 4 days in most epidemics.http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
23/52
Diagnosis of Pneumonic Plague Infection FollowingUse of a Biological Weapon
Epidemiology and symptoms
Sudden appearance of many persons with fever,
cough, shortness of breath, hemoptysis, and chest pain Gastrointestinal symptoms common (eg, nausea,
vomiting, abdominal pain, and diarrhea)
Patients have fulminant course and high mortality
Clinical signs: Tachypnea, dyspnea, and cyanosis Pneumonic consolidation on chest examination
http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
24/52
Sepsis, shock, and organ failure Infrequent presence of cervical bubo (Purpuric skin lesions and necrotic digits only in advanced
disease) Laboratory studies Sputum, blood, or lymph node aspirate
Gram-negative bacilli with bipolar (safety pin) staining on Wright,Giemsa, or Wayson stain Rapid diagnostic tests available only at some health departments,
the Centers for Disease Control and Prevention, and military laboratories Pulmonary infiltrates or consolidation on chest radiograph Pathology Lobular exudation, bacillary aggregation, and areas of
necrosis in pulmonary Parenchyma http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
25/52
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
26/52
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
27/52
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
28/52
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
29/52
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
30/52
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
31/52
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
32/52
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
33/52
Working Group Recommendations for Treatment of Patients WithPneumonic
Plague in the Contained and Mass Casualty Settings and for Post-exposure Prophylaxis*
Patient Category Recommended Therapy Contained Casualty Setting
Adults Preferred choices Streptomycin, 1 g IM twice daily Gentamicin, 5 mg/kg IM or IV once daily or 2 mg/kg loading dose
followed by 1.7 mg/kg IM or IV 3 times daily Alternative choices
Doxycycline, 100 mg IV twice daily or 200 mg IV once daily Ciprofloxacin, 400 mg IV twice daily Chloramphenicol, 25 mg/kg IV 4 times daily http://www.bt.cdc.gov/agent/plague/consensus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
34/52
Mass Casualty Setting and PostexposureProphylaxis.
Adults Preferred choices
Doxycycline, 100 mg orally twice daily Ciprofloxacin, 500 mg orally twice daily
Alternative choice
Chloramphenicol, 25 mg/kg orally 4 times
daily http://www.bt.cdc.gov/agent/plague/consen
sus.pdf
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
35/52
Plague BIOLOGICAL WEAPON.
Can be resistant to any form of antibiotics.
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
36/52
Plague treatment with Na Cl O. : ,
, , , , -
. Method of treatment with Sodium hypochlorite
currently in use in medical practice for treatmentof different forms of Viral Infections - Viralhepatitis; human immunodeficiency virus(HIV)
is a lentivirus (a subgroup of retrovirus) thatcauses the acquired immunodeficiency syndrome(AIDS); different forms of herpes.
Can we use this method for Plague treatment?
https://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&sqi=2&ved=0CB0QFjAA&url=http://en.wikipedia.org/wiki/Viral_hepatitis&ei=z8FPVJysKISVyATFv4HYBg&usg=AFQjCNES_oJiMH-aHUkooYpfiJlqQViOqA&sig2=eQbmeqSsjTw_Bdbwcxc4mg&bvm=bv.77880786,d.aWwhttps://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&sqi=2&ved=0CB0QFjAA&url=http://en.wikipedia.org/wiki/Viral_hepatitis&ei=z8FPVJysKISVyATFv4HYBg&usg=AFQjCNES_oJiMH-aHUkooYpfiJlqQViOqA&sig2=eQbmeqSsjTw_Bdbwcxc4mg&bvm=bv.77880786,d.aWwhttps://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&sqi=2&ved=0CB0QFjAA&url=http://en.wikipedia.org/wiki/Viral_hepatitis&ei=z8FPVJysKISVyATFv4HYBg&usg=AFQjCNES_oJiMH-aHUkooYpfiJlqQViOqA&sig2=eQbmeqSsjTw_Bdbwcxc4mg&bvm=bv.77880786,d.aWwhttps://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&sqi=2&ved=0CB0QFjAA&url=http://en.wikipedia.org/wiki/Viral_hepatitis&ei=z8FPVJysKISVyATFv4HYBg&usg=AFQjCNES_oJiMH-aHUkooYpfiJlqQViOqA&sig2=eQbmeqSsjTw_Bdbwcxc4mg&bvm=bv.77880786,d.aWwhttps://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&sqi=2&ved=0CB0QFjAA&url=http://en.wikipedia.org/wiki/Viral_hepatitis&ei=z8FPVJysKISVyATFv4HYBg&usg=AFQjCNES_oJiMH-aHUkooYpfiJlqQViOqA&sig2=eQbmeqSsjTw_Bdbwcxc4mg&bvm=bv.77880786,d.aWwhttps://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&sqi=2&ved=0CB0QFjAA&url=http://en.wikipedia.org/wiki/Viral_hepatitis&ei=z8FPVJysKISVyATFv4HYBg&usg=AFQjCNES_oJiMH-aHUkooYpfiJlqQViOqA&sig2=eQbmeqSsjTw_Bdbwcxc4mg&bvm=bv.77880786,d.aWw -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
37/52
Dilute bleach baths have been used for decadesto treat moderate to severe eczemain humans,
but it has not been clear why they work.According to work published by researchers at
the Stanford University School of MedicineinNovember 2013, a very dilute (0.005%) solutionof sodium hypochlorite in water was successfulin treating skin damage with
an inflammatorycomponent causedby radiation therapy, excess sun exposure oraging in laboratory mice.
http://en.wikipedia.org/wiki/Eczemahttp://en.wikipedia.org/wiki/Stanford_University_School_of_Medicinehttp://en.wikipedia.org/wiki/Inflammationhttp://en.wikipedia.org/wiki/Radiation_therapyhttp://en.wikipedia.org/wiki/Laboratory_micehttp://en.wikipedia.org/wiki/Laboratory_micehttp://en.wikipedia.org/wiki/Radiation_therapyhttp://en.wikipedia.org/wiki/Inflammationhttp://en.wikipedia.org/wiki/Stanford_University_School_of_Medicinehttp://en.wikipedia.org/wiki/Eczema -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
38/52
Sodium hypochlorite solution for intravenousinfusions was produced by electrolysis with devicefor electrochemical method of elaboration from
NaCl isotonic (0,89%) solution. 200400 ml of 002 %-0,03% sodium hypochlorite
solution usually administered drop-by-drop intoan the median cubital vein(or median basilic
vein) is a superficial veinof the upper limbvein atthe rate of 30-40 drops per minute. A course oftreatment included 20 procedures 1-3 proceduresevery 24 hours (depended on severity of diseases).
http://en.wikipedia.org/wiki/Superficial_veinhttp://en.wikipedia.org/wiki/Upper_limbhttp://en.wikipedia.org/wiki/Upper_limbhttp://en.wikipedia.org/wiki/Superficial_vein -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
39/52
Plague: Treatment with Na Cl O, IV, endo-lymphatic.
( N 418
13.04.91). Approved by National Pharmaceutical
Department. Ministry of Public Health. Russia.
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
40/52
Advantages& disadvantages.
1. Sodium hypochloriteis a chemical
compoundwith the formulaNa Cl O - wellknown disinectant preparation and used fordestruction of viruses and bacteria on externalsurfaces.
2. Sodium hypochlorite is a Disinfectant.
3. http://en.wikipedia.org/wiki/Disinfectant
http://en.wikipedia.org/wiki/Chemical_compoundhttp://en.wikipedia.org/wiki/Chemical_compoundhttp://en.wikipedia.org/wiki/Chemical_formulahttp://en.wikipedia.org/wiki/Chemical_formulahttp://en.wikipedia.org/wiki/Chemical_compoundhttp://en.wikipedia.org/wiki/Chemical_compound -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
41/52
Advantages& disadvantages.
Approved by National PharmaceuticalDepartment. Ministry of Public Health. Russia.
Method can be used for medical managementfor millions acutely and severe ill people inshort time.
Method already used in clinical conditions fortreatment patients with viral hepatitis andintoxication with chemical and biologicaltoxins.
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
42/52
Disinfectantsare antimicrobial agentsthat are applied to non-livingobjects to destroy microorganismsthat are living on the objects.
Disinfection does not necessarily kill all microorganisms, especiallyresistant bacterial spores; it is less effective than sterilization, which is anextreme physical and/or chemical process that kills all types of life.
Disinfectants are different from other antimicrobial agents suchas antibiotics, which destroy microorganisms within the body,and antiseptics, which destroy microorganisms on living tissue.Disinfectants are also different from biocidesthe latter are intended todestroy all forms of life, not just microorganisms. Disinfectants work bydestroying the cell wall of microbes or interfering with the metabolism.
Bacterial endosporesare most resistant to disinfectants, but some virusesand bacteria also possess some tolerance.
Disinfectants are frequently used in hospitals, dental surgeries, kitchens,and bathrooms to kill infectious organisms.
http://en.wikipedia.org/wiki/Disinfectant#Oxidizing_agents
http://en.wikipedia.org/wiki/Microorganismshttp://en.wikipedia.org/wiki/Antimicrobialhttp://en.wikipedia.org/wiki/Microorganismshttp://en.wikipedia.org/wiki/Endosporehttp://en.wikipedia.org/wiki/Sterilization_(microbiology)http://en.wikipedia.org/wiki/Endosporehttp://en.wikipedia.org/wiki/Sterilization_(microbiology)http://en.wikipedia.org/wiki/Antibiotichttp://en.wikipedia.org/wiki/Antibiotichttp://en.wikipedia.org/wiki/Antiseptichttp://en.wikipedia.org/wiki/Antiseptichttp://en.wikipedia.org/wiki/Biological_tissuehttp://en.wikipedia.org/wiki/Antiseptichttp://en.wikipedia.org/wiki/Biocidehttp://en.wikipedia.org/wiki/Biological_tissuehttp://en.wikipedia.org/wiki/Biocidehttp://en.wikipedia.org/wiki/Endosporehttp://en.wikipedia.org/wiki/Endosporehttp://en.wikipedia.org/wiki/Biocidehttp://en.wikipedia.org/wiki/Biological_tissuehttp://en.wikipedia.org/wiki/Antiseptichttp://en.wikipedia.org/wiki/Antibiotichttp://en.wikipedia.org/wiki/Sterilization_(microbiology)http://en.wikipedia.org/wiki/Endosporehttp://en.wikipedia.org/wiki/Microorganismshttp://en.wikipedia.org/wiki/Antimicrobial -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
43/52
Oxidizing agentsact by oxidizing the cellmembrane of microorganisms, which results ina loss of structure and leads to cell lysisand
death. A large number of disinfectants operatein this way. Chlorineand oxygenare strongoxidizers.
http://en.wikipedia.org/wiki/Disinfectant#O
xidizing_agents
http://en.wikipedia.org/wiki/Redoxhttp://en.wikipedia.org/wiki/Lysishttp://en.wikipedia.org/wiki/Chlorinehttp://en.wikipedia.org/wiki/Oxygenhttp://en.wikipedia.org/wiki/Oxygenhttp://en.wikipedia.org/wiki/Chlorinehttp://en.wikipedia.org/wiki/Lysishttp://en.wikipedia.org/wiki/Redox -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
44/52
Sodium hypochloriteis very commonly used. Commonhousehold bleachis a sodium hypochlorite solutionand is used in the home to disinfect different surfaces.In more dilute form, it is used in swimming pools, andin still more dilute form, it is used in drinking water.
When pools and drinking water are said to bechlorinated, it is actually sodium hypochlorite or arelated compoundnot pure chlorinethat is beingused. Chlorine partly reacts with proteinaceous liquidssuch as blood to form non-oxidizing N-chlorocompounds, and thus higher concentrations must beused if disinfecting surfaces after blood spills.
In more diluted and ionized form can be used for I/Vadministration and treatment for deadly, severe formof viral or bacterial infection.
http://en.wikipedia.org/wiki/Sodium_hypochloritehttp://en.wikipedia.org/wiki/Bleachhttp://en.wikipedia.org/wiki/Sodium_hypochloritehttp://en.wikipedia.org/wiki/Bleachhttp://en.wikipedia.org/wiki/Bleachhttp://en.wikipedia.org/wiki/Sodium_hypochlorite -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
45/52
Electrolyzed wateror "Anolyte" is an oxidizing,acidic hypochlorite solution madeby electrolysisof sodium chlorideinto sodium
hypochloriteand hypochlorous acid. Anolytehas an oxidation-reduction potential of +600 to+1200 mV and a typical pH range of 3.58.5,but the most potent solution is produced at a
controlled pH 5.06.3 where the predominantoxychlorine species is hypochlorous acid.
http://en.wikipedia.org/wiki/Electrolyzed_waterhttp://en.wikipedia.org/wiki/Electrolysishttp://en.wikipedia.org/wiki/Sodium_chloridehttp://en.wikipedia.org/wiki/Sodium_hypochloritehttp://en.wikipedia.org/wiki/Sodium_hypochloritehttp://en.wikipedia.org/wiki/Hypochlorous_acidhttp://en.wikipedia.org/wiki/Hypochlorous_acidhttp://en.wikipedia.org/wiki/Hypochlorous_acidhttp://en.wikipedia.org/wiki/Hypochlorous_acidhttp://en.wikipedia.org/wiki/Sodium_hypochloritehttp://en.wikipedia.org/wiki/Sodium_hypochloritehttp://en.wikipedia.org/wiki/Sodium_chloridehttp://en.wikipedia.org/wiki/Electrolysishttp://en.wikipedia.org/wiki/Electrolyzed_water -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
46/52
A method of treating acute generalized Plaguecomprising performing medical treatment ,wherein the treatment consists in IV or endo-
lymphatic administration of an aqueoussolution of sodium hypochlorite.
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
47/52
Sodium hypochloriteis a chemicalcompoundwith the formulaNaClO.It is composed of
a sodiumcation(Na+) and a hypochloriteanion(ClO); it mayalso be viewed as thesodium saltof hypochlorous acid.
http://en.wikipedia.org/wiki/Chemical_compoundhttp://en.wikipedia.org/wiki/Chemical_compoundhttp://en.wikipedia.org/wiki/Chemical_formulahttp://en.wikipedia.org/wiki/Sodiumhttp://en.wikipedia.org/wiki/Cationhttp://en.wikipedia.org/wiki/Hypochloritehttp://en.wikipedia.org/wiki/Anionhttp://en.wikipedia.org/wiki/Salt_(chemistry)http://en.wikipedia.org/wiki/Hypochlorous_acidhttp://en.wikipedia.org/wiki/Hypochlorous_acidhttp://en.wikipedia.org/wiki/Hypochlorous_acidhttp://en.wikipedia.org/wiki/Hypochlorous_acidhttp://en.wikipedia.org/wiki/Salt_(chemistry)http://en.wikipedia.org/wiki/Anionhttp://en.wikipedia.org/wiki/Hypochloritehttp://en.wikipedia.org/wiki/Cationhttp://en.wikipedia.org/wiki/Sodiumhttp://en.wikipedia.org/wiki/Chemical_formulahttp://en.wikipedia.org/wiki/Chemical_compoundhttp://en.wikipedia.org/wiki/Chemical_compound -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
48/52
A new effective method of countermeasureagainst biological weapons, antiviral treatmentof acute and chronic viral hepatitis B and C and
against other viral diseases was used inmedical practice in hospitals.Research show this method as effective methodagainst severe viral infections, warfare, and
outbreak infections, Biological warfare,methicillin-resistant staphylococcus aureus.
-
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
49/52
Equipment: Mobile and Industrial.
Cost effective, Simple, Effective Therapy.
http://iadt.siemens.ru/assets/files/news/OS
EC.pdf http://www.niitop.ru/site.aspx?IID=2139510
&SECTIONID=2074568
http://iadt.siemens.ru/assets/files/news/OSEC.pdfhttp://iadt.siemens.ru/assets/files/news/OSEC.pdfhttp://iadt.siemens.ru/assets/files/news/OSEC.pdfhttp://iadt.siemens.ru/assets/files/news/OSEC.pdfhttp://www.niitop.ru/site.aspx?IID=2139510&SECTIONID=2074568http://www.niitop.ru/site.aspx?IID=2139510&SECTIONID=2074568http://www.niitop.ru/site.aspx?IID=2139510&SECTIONID=2074568http://www.niitop.ru/site.aspx?IID=2139510&SECTIONID=2074568http://iadt.siemens.ru/assets/files/news/OSEC.pdfhttp://iadt.siemens.ru/assets/files/news/OSEC.pdfhttp://iadt.siemens.ru/assets/files/news/OSEC.pdfhttp://iadt.siemens.ru/assets/files/news/OSEC.pdfhttp://iadt.siemens.ru/assets/files/news/OSEC.pdfhttp://iadt.siemens.ru/assets/files/news/OSEC.pdf -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
50/52
http://carakurt.narod.ru/hipohlorit_Na.htm
http://www.naclo.ru/opublikovannyie-stati/type/2/126/
http://www.naclo.ru/en/ http://www.dissercat.com/content/gipokhlor
it-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pecheni
http://irbis.ismu.baikal.ru/smg/2008-6/18.pdf
http://carakurt.narod.ru/hipohlorit_Na.htmhttp://www.naclo.ru/opublikovannyie-stati/type/2/126/http://www.naclo.ru/opublikovannyie-stati/type/2/126/http://www.naclo.ru/en/http://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://irbis.ismu.baikal.ru/smg/2008-6/18.pdfhttp://irbis.ismu.baikal.ru/smg/2008-6/18.pdfhttp://irbis.ismu.baikal.ru/smg/2008-6/18.pdfhttp://irbis.ismu.baikal.ru/smg/2008-6/18.pdfhttp://irbis.ismu.baikal.ru/smg/2008-6/18.pdfhttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.dissercat.com/content/gipokhlorit-natriya-v-lechenii-bolnykh-khronicheskimi-diffuznymi-zabolevaniyami-pechenihttp://www.naclo.ru/en/http://www.naclo.ru/opublikovannyie-stati/type/2/126/http://www.naclo.ru/opublikovannyie-stati/type/2/126/http://www.naclo.ru/opublikovannyie-stati/type/2/126/http://carakurt.narod.ru/hipohlorit_Na.htm -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
51/52
http://www.ikar.udm.ru/sb/sb36-2.htm
http://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-
kompleksnom-lechenii-oslozhnenii-ostrogo-pa http://bankpatentov.ru/node/349358
http://www.findpatent.ru/patent/208/2089194.html
http://www.ikar.udm.ru/sb/sb36-2.htmhttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://bankpatentov.ru/node/349358http://www.findpatent.ru/patent/208/2089194.htmlhttp://www.findpatent.ru/patent/208/2089194.htmlhttp://www.findpatent.ru/patent/208/2089194.htmlhttp://www.findpatent.ru/patent/208/2089194.htmlhttp://bankpatentov.ru/node/349358http://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.dissercat.com/content/primenenie-gipokhlorita-natriya-i-sandostatina-v-kompleksnom-lechenii-oslozhnenii-ostrogo-pahttp://www.ikar.udm.ru/sb/sb36-2.htmhttp://www.ikar.udm.ru/sb/sb36-2.htmhttp://www.ikar.udm.ru/sb/sb36-2.htm -
8/10/2019 PLAGUE: Medical Management and Countermeasure Development.
52/52
Many Thanks to Thomas V. Inglesby, MD David T. Dennis, MD, MPH Donald A. Henderson, MD, MPH John G. Bartlett, MD Michael S. Ascher, MD Edward Eitzen, MD, MPH Anne D. Fine, MD Arthur M. Friedlander, MD Jerome Hauer, MPH John F. Koerner, MPH, CIH Marcelle Layton, MD Joseph McDade, PhD Michael T. Osterholm, PhD, MPH Tara OToole, MD, MPH Gerald Parker, PhD, DVM Trish M. Perl, MD, MSc Philip K. Russell, MD Monica Schoch-Spana, PhD
Kevin Tonat, DrPH, MPH for the Working Group on Civilian Biodefense http://www.bt.cdc.gov/agent/plague/consensus.pdf And many others.
http://www.bt.cdc.gov/agent/plague/consensus.pdfhttp://www.bt.cdc.gov/agent/plague/consensus.pdf